Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Medicine|July 12, 2025
Cardiorenal Syndrome in Adults with Congenital Heart DiseaseShailendra Upadhyay, Anudeep K Dodeja, Olga Toro-Salazar, et al.
Neuro-Oncology|January 18, 2020
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responsesAndrea Comba, Patrick J Dunn, Anna E Argento, et al.
British Journal of Clinical Pharmacology|September 17, 2021
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignanciesHelena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with AcalabrutinibAnfal Alsadhan, Jean Cheung, Michael Gulrajani, et al.
JAMA|June 10, 2010
Infection control assessment of ambulatory surgical centersMelissa K Schaefer, Michael Jhung, Marilyn Dahl, et al.
Cancer Science|March 17, 2021
Safety and antitumor activity of acalabrutinib for relapsed/refractory B-cell malignancies: A Japanese phase I studyKoji Izutsu, Kiyoshi Ando, Daisuke Ennishi, et al.
British Journal of Clinical Pharmacology|April 25, 2022
Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjectsShringi Sharma, Xavier Pepin, Jean Cheung, et al.
Pageof 8